EP3415531
BCMA (CD269/TN FRSFl 7) - MÓTEFNAVAKABINDANDI PRÓTEIN
:
EP einkaleyfi í gildi á Íslandi:
24.5.2012:
6.9.2023:
18163942.8
:
7.9.2023:
15.11.2023
:
23.5.2032:
23.5.2026:
31.5.2026
:
BCMA (CD269/TNFRSF17) - BINDING PROTEINS
24.5.2012
6.9.2023
7.9.2023
15.11.2023
23.5.2026
:
Glaxo Group Limited:
GSK Medicines Research Centre Gunnels Wood Road, Stevenage SG1 2NY, GB
:
ALGATE, Paul:
Issaquah, WA, US
:
CLEGG, Stephanie Jane:
Stevenage, Hertfordshire SG1 2NY, GB
:
CRAIGEN, Jennifer L.:
Stevenage, Hertfordshire SG1 2NY, GB
:
HAMBLIN, Paul Andrew:
Stevenage, Hertfordshire SG1 2NY, GB
:
LEWIS, Alan Peter:
Stevenage, Hertfordshire SG1 2NY, GB
:
PARMAR, Radha Shah:
Stevenage, Hertfordshire SG1 2NY, GB
:
MAYES, Patrick:
Collegeville, PA 19426-0989, US
:
WATTAM, Trevor Anthony Kenneth:
Stevenage, Hertfordshire SG1 2NY, GB
:
Tego IP ehf.:
Pósthólf 8129, 128, Reykjavík,
:
201161490732 P:
27.5.2011:
US
:
201261647196 P:
15.5.2012:
US
:
SPC439
:
C07K 16/28, A61K 39/00, A61K 47/68
: 13
: 19.4.2024
: 23.5.2025
: Árnason Faktor ehf.
: 14
: 13.5.2025
: 23.5.2026
: Árnason Faktor ehf.